Gofen & Glossberg LLC Organon & Co. Transaction History

Gofen & Glossberg LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	SELL	$31.66 - $38.9 $201,800 - $247,948	-6,374 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$30.45 - $39.36 $218,539 - $282,486	-7,177 Reduced 52.96%	6,374 $223,000
Q4 2021 Jan 25, 2022	SELL	$28.67 - $37.13 $78,297 - $101,402	-2,731 Reduced 16.77%	13,551 $413,000
Q3 2021 Oct 13, 2021	SELL	$28.63 - $35.64 $186,839 - $232,586	-6,526 Reduced 28.61%	16,282 $534,000
Q2 2021 Jul 13, 2021	BUY	$28.45 - $38.0 $648,887 - $866,704	22,808 New	22,808 $690,000

793

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.71B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

Stay updated on Gofen & Glossberg LLC with notifications on news.